Tumor-derived EVs could also induce immune exhaustion in the tumor microenvironment through upregulating the expression of inhibitory molecules of lymphocytes such as NK cells and CD8 positive T-lymphocytes or enhancing the differentiation of myeloid-derived suppressor cells (Lane et al., 2018). The gene discussed is CD8A; the disease is neoplasm.